Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Jones

Showing results (871-880 of 3,162) with videos related to

Pageof 317
Sort By:
Diagnostic Microbiology and Infectious Disease|May 10, 2005
Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanismsRonald N Jones, Helio S Sader, Thomas R Fritsche
Diagnostic Microbiology and Infectious Disease|August 18, 2005
Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003)Helio S Sader, Thomas R Fritsche, Ronald N Jones
Diagnostic Cytopathology|March 4, 2006
Fine-needle aspiration cytology of the thyroid: ten years experience in a community teaching hospitalHoward Her-Juing Wu, Jennifer N Jones, Jailan Osman
Diagnostic Microbiology and Infectious Disease|November 21, 1998
Activity of a broad-spectrum cephalosporin (Ro 48-8391) alone and in combination with two novel beta-lactamase inhibitors (Ro 48-5545 and Ro 48-8724)R N Jones, S A Marshall, D J Varnam
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1993
In vitro activity of E-4868, a new trifluoroquinolone, compared to six similar compoundsM S Barrett, R N Jones, M E Erwin
Diagnostic Microbiology and Infectious Disease|April 4, 2008
Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006)Thomas R Fritsche, Helio S Sader, Ronald N Jones
International Journal of Antimicrobial Agents|December 9, 2003
Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997-2001)Ronald N Jones, Helio S Sader, Mondell L Beach
The Annals of Pharmacotherapy|March 16, 2002
Pharmacodynamics in the evaluation of drug regimensSujata M Bhavnani, Paul G Ambrose, Ronald N Jones
Bulletin of the World Health Organization|January 1, 1993
Occupational exposure of Sri Lankan tea plantation workers to paraquatG Chester, G Gurunathan, N Jones, et al.
Biochimica Et Biophysica Acta|February 25, 1991
The effect of surface-bound protein on the permeability of proteoliposomesS E Francis, I G Lyle, M N Jones
Pageof 317

Showing results (871-880 of 3,162) with videos related to

Sort By:
Pageof 317
Diagnostic Microbiology and Infectious Disease|May 10, 2005
Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanismsRonald N Jones, Helio S Sader, Thomas R Fritsche
Diagnostic Microbiology and Infectious Disease|August 18, 2005
Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003)Helio S Sader, Thomas R Fritsche, Ronald N Jones
Diagnostic Cytopathology|March 4, 2006
Fine-needle aspiration cytology of the thyroid: ten years experience in a community teaching hospitalHoward Her-Juing Wu, Jennifer N Jones, Jailan Osman
Diagnostic Microbiology and Infectious Disease|November 21, 1998
Activity of a broad-spectrum cephalosporin (Ro 48-8391) alone and in combination with two novel beta-lactamase inhibitors (Ro 48-5545 and Ro 48-8724)R N Jones, S A Marshall, D J Varnam
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1993
In vitro activity of E-4868, a new trifluoroquinolone, compared to six similar compoundsM S Barrett, R N Jones, M E Erwin
Diagnostic Microbiology and Infectious Disease|April 4, 2008
Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006)Thomas R Fritsche, Helio S Sader, Ronald N Jones
International Journal of Antimicrobial Agents|December 9, 2003
Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997-2001)Ronald N Jones, Helio S Sader, Mondell L Beach
The Annals of Pharmacotherapy|March 16, 2002
Pharmacodynamics in the evaluation of drug regimensSujata M Bhavnani, Paul G Ambrose, Ronald N Jones
Bulletin of the World Health Organization|January 1, 1993
Occupational exposure of Sri Lankan tea plantation workers to paraquatG Chester, G Gurunathan, N Jones, et al.
Biochimica Et Biophysica Acta|February 25, 1991
The effect of surface-bound protein on the permeability of proteoliposomesS E Francis, I G Lyle, M N Jones
Pageof 317